GovChime
Notice ID: cbd1b8a2fbc943f48458acd0249992acSolicitation

Pharmacokinetic and Pharmacodynamic Trials for Medication Development in SUD

Archived on December 30, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM UTC−05:00
Posted
January 19, 2023
Notice type
Solicitation
NAICS
541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95023R00002
Notice ID
cbd1b8a2fbc943f48458acd0249992ac

Description

The National Institute on Drug Abuse invites you to submit a proposal responding to the requirements of this RFP No. 75N95023R00002 titled Pharmacokinetic and Pharmacodynamic Trials for Medication Development in SUD . Please refer to Section M for mandatory criteria. All offerors must be REGISTERED and have an ACTIVE System for Award Management "http://www.sam.gov/"(www.sam.gov) account at the time an offer/proposal is submitted to the Government. All offerors registered in the System for Award Management http://www.sam.gov/ (www.sam.gov) must be in full compliance with FAR 52.204-13 System for Award Management Maintenance to be eligible to submit a proposal. The Government will not accept proposals from offerors who do not meet the SAM requirement. This RFP is prepared in accordance with the Uniform Contract Format (UCF) prescribed for Government wide application by the Federal Acquisition Regulation (FAR). The UCF is both an RFP and contract award document. The resulting contract will consist of Parts I, II, III of the Uniform Contract Format. NIDA anticipates that one (1) indefinite delivery, indefinite quantity (IDIQ), task order contract will be awarded with a contract ordering period of five (5) years. NIDA may award either cost reimbursement and/or fixed price task orders under this contract. These individual task orders may include options and/or options quantities. If options or option quantities are utilized for an individual task order the will be clearly defined in the Task Order RFP and be determined and evaluated at the time of task order solicitation and award. NIDA anticipates that at least one task order will be awarded with the contract. Future funding will be made through issuances of task orders and will be dependent on NIDA programmatic needs and availability of funds. Set-Aside Status: The services will be acquired through unrestricted full and open competitive procedures under NAICS Code 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Anticipated Ordering Period: The anticipated ordering period is five years. Proposal Due Date: Proposals must be submitted via the electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov) no later than December 15, 2022 3:00 P.M. Eastern Time

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95023R00002
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. 4×
    SolicitationCurrentNov 3, 2022

    Pharmacokinetic and Pharmacodynamic Trials for Medication Development in SUD

    Notice cbd1b8a2fbc943f48458acd0249992ac on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95023R00002

Archive Date

Dec 30, 2022

Office Address

Bethesda, MD, 20892